Emcure Pharma
₹1,820.6-15.40 (-0.84%)as of 2026-10-16
- Market Cap
- ₹34,570Cr.
- P/E Ratio
- 33.6
- P/B Ratio
- 6.98
- EPS (TTM)
- ₹54.18
- Day Range
- ₹1,816.2 – ₹1,849.3
- Div Yield
- 0.19%
- ROCE
- 24%
- ROE
- 20.1%
52W Low: ₹1,30652W High: ₹2,101
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 15.0% a year over three years.
- Debt is 0.31× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Emcure_Pharma — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 33.6P/E: 33.6 | P/B: 6.98Growth
GrowingSales CAGR — 3Y: 15% · 1Y: 18%Profitability
High MarginROCE: 24% | ROE: 20.1%Key Metrics
Valuation
PEG Ratio 1.60
Price / Sales 3.57x
Price / FCF 86.4x
Book Value ₹261
Margins & returns
Operating Margin 20%
Net Margin 10.5%
Return on Assets 10.7%